Douglas Pharmaceuticals stays in family

Last updated 14:46 30/11/2012

Relevant offers


Former GNS Science chief executive was highest-earning CRI boss on $800,000 Banker involved in alleged mortgage fraud fights for name suppression Cloud computing: get with it or get left behind Australian deal triggers option for NZME to acquire 3000 advertising panels Young have biggest reservations about the 'pros and cons' of the internet Mad Butcher Tauranga in liquidation after months of poor trading World Bank names NZ best country for business WorkSafe to investigate trampoline parks after rise in injuries No simple link between media competition and story choice, says US professor Job listings on Seek spike in September as big retailers open stores

The founder of Douglas Pharmaceuticals, the country’s largest drug manufacturer, has decided his business will remain in New Zealand hands.

Earlier this year Sir Graeme Douglas denied that the company was being touted to a major Canadian drugs firm, or to anyone else.

However the family-owned firm confirmed it had indeed recently put out an Information Memorandum to prospective purchasers.

It had decided to formalise the process after receiving several offers from interested parties over the years.

Having reviewed the bids, Sir Graeme decided the best way forward was to retain private ownership.

‘‘Along with my board, I remain committed and passionate about the future of our New Zealand-manufactured pharmaceuticals enjoying ever-increasing success in the world markets,’’ he said in a statement this afternoon.

The company plans to boost its exports by adding experienced executives with the emphasis on emerging markets in Asia and Latin America.

Douglas Pharmaceuticals was founded by Sir Graeme in 1967. It makes a range of products for immuno-suppression, oncology, dermatology and the central nervous system, and exports to 45 countries worldwide.

Ad Feedback


Special offers

Featured Promotions

Sponsored Content